Result of AGM
Updated : 15:18
Cambridge Cognition Holdings Plc
("Cambridge Cognition" or the "Company")
Result of AGM
Cambridge Cognition, which develops and markets digital solutions to assess brain health, held its Annual General Meeting ("AGM") earlier today at the registered office of the Company; Tunbridge Court, Tunbridge Lane, Bottisham, Cambridge, CB25 9TU. Resolutions 1 to 6 put to the AGM were duly passed and resolution 7 was not passed.
Proxy votes were received in respect of approximately 34% of the Company's issued share capital and the proxy votes received in respect of each resolution were as follows:
Resolution | For |
| Against |
| Withheld |
1 - To approve the 2021 report and accounts | 9,609,585 | 90.23% | 1,040,000 | 9.77% | 133 |
2 - To reappoint the auditors | 10,643,921 | 99.95% | 5,664 | 0.05% | 133 |
3 - to authorise the directors to set the auditors remuneration | 10,649,585 | 100.00% | 0 | 0.00% | 133 |
4 - to re-elect Steven Powell as a director | 10,630,812 | 99.99% | 547 | 0.01% | 18,359 |
5 - to re-elect Matthew Stork as a director | 10,631,159 | 99.99% | 200 | 0.01% | 18,359 |
6 - authority to allot shares | 9,606,038 | 90.23% | 1,040,200 | 9.77% | 3,480 |
7 - disapplication of pre-emption rights | 5,188,039 | 48.73% | 5,458,199 | 51.27% | 3,480 |
Enquiries
Cambridge Cognition Holdings plc Matthew Stork, Chief Executive Officer Stephen Symonds, Chief Financial Officer | Tel: 01223 810 700
|
Panmure Gordon (UK) Limited (NOMAD and Joint Broker) Freddy Crossley / Emma Earl / Mark Rogers Rupert Dearden | Tel: 020 7220 0500 (Corporate Advisory) (Corporate Broking) |
Dowgate Capital Limited (Joint Broker) David Poutney / James Serjeant | Tel: 020 3903 7715 (Corporate Broking) |
IFC Advisory Ltd (Financial PR and IR) Tim Metcalfe / Graham Herring / Zach Cohen | Tel: 020 3934 6630
|
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.